Yarrow Bioscience, Inc.
YARW · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Payton Lori: Form 4
Insider disclosure · Filed · Report period 29 Oct 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form SCHEDULE 13G
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001566044 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- YARW on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 470 James Street, Suite 007, New Haven, CT, 06513
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
-
VYNE Therapeutics Inc. (to 24 Jul 2026) Menlo Therapeutics Inc. (to 02 Sep 2020) Menlo Therapeutics Inc. (to 31 Jan 2018) Tigercat Pharma Inc. (to 07 Jan 2013)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields